Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-29

Clinical Trial Update: Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating low-dose total skin electron beam radiation therapy with mechlorethamine hydrochloride gel for Mycosis Fungoides has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mechlorethamine hydrochloride gel (mechlorethamine hydrochloride)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Mycosis Fungoides | Phase 2 | Status: WITHDRAWN